DOI: https://doi.org/10.15587/2313-8416.2015.48819

Anesthetic management of operations in patients with concomitant arterial hypertension.

Олег Анатольевич Лоскутов

Abstract


Tactical approaches to anesthetic management of patients with contaminant arterial hypertension (AH) are considered in this work.

The aim of research was the generalization of data of scientific literature and our own experience in anesthetic management of patients with contaminant AH and elaboration of practical recommendations for preparation and intra-operative conducting of this contingent of patients.

Methods. The work is based on the results of clinic studies that were carried out in 208 cardiosurgical patients 56-69 years old with contaminant AH.

Our own experience and the base of internet-data in “Google” and “PubMed” were analyzed.

Results. As the result of the work there were elaborated the practical recommendations for pre-operative preparation and anesthetic management of patients with contaminant AH.

Conclusions. An introduction of the elaborated record into practice allowed to reduce the number of complications in patients with AH from 28,7% to 7,4% and gave a possibility for successful operations of patients with heavy forms of AH


Keywords


Keywords: arterial hypertension; pre-operative anti-hypertension therapy; anesthesia at contaminant arterial hypertension

References


Pereira, M., Lunet, N., Azevedo, A., Barros, H. (2009). Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. Journal of Hypertension, 27 (5), 963–975. doi: 10.1097/hjh.0b013e3283282f65

Vershigora, A. V., Grankina, I. M., Gidzinska, I. M. (2013). Uniphikovanii klinichnii protocol pervinnoi, ekstrenoi ta vtorinoi (specializovanoi) medichnoi dopomogi [Standardized clinical protocol primary, emergency and secondary (specialized) medical care] (2012). Arterialna gipertenzia [Arterial hypertension]. Practicing physician. 4, 59–63.

Lawes, C. M., Hoorn, S. V., Rodgers, A. (2008). Global burden of blood-pressure-related disease, 2001. The Lancet, 371 (9623), 1513–1518. doi: 10.1016/S0140-6736(08)60655-8

Sirenko, Y. N. (2011). Gipertonicheskay bolezn i arterialnie gipertenzii [Hypertonic disease and arterial hypertension]. Published Zaslavsky A. Y., 288.

Svishenko,, E. P., Bagrii A. E., Ena, L. M. et. al. (2008). Rekomendacii Ukrainskoi asociacii kardiologov я profilaktiki ta likyvanny arterialnoi gipertenzii (Posibnik do Nacionalnoi programi profilaktiki I likyvanny arterialnoi gipertenzii. IV vidanny) [Recommendations of the Ukrainian Association of Cardiology on prevention and treatment of arterial hypertension (National Program to Benefit the prevention and treatment of hypertension. The fourth edition)]. Kyiv: PP VMB, 80.

Proshaev, K. I. (2005). Taktika i osobennosti vedeniy bolnih s arterialnoi gipertenziei v pozilom I starcheskom vozraste pri hirurgicheskih vmeshatelstvah [Tactics and features of the management of patients with hypertension in elderly and senile age at surgery]. St. Petersburg Institute Bioregulation and Gerontology of the North-West Branch of the Russian Academy of Medical Sciences. St. Petersburg, 305.

Mangano, D. T. (2004). Perioperative medicine: NHLBI working group deliberations and recommendations. Journal of Cardiothoracic and Vascular Anesthesia, 18 (1), 1–6. doi: 10.1053/j.jvca.2003.10.002

Manjula, S., Lalita, D., Shilpa, R. (2007). Analysis of anaesthetic intensive care unit admissions: The anaesthesiologists' perspective. The Internet Journal of Anesthesiology, 13 (1), 5–11.

Muggli, F., Suter, P. M. (2013). How to deal with preoperative hypertension. Praxis (Bern 1994). 102 (21), 1293–1297. doi: 10.1024/1661-8157/a001438

Faergeman, O., Hill, L., Windler, E., Wiklund, O., Asmar, R., Duffield, E., Sosef, F. (2008). Efficacy and tolerability of rosuvastatin and atorvastatin when force-titrated in patients with primary hypercholesterolemia: results from the ECLIPSE study. Cardiology. 111 (4), 219–228.

Wright, J. M., Musini, V. M. (2009). First-line drugs for hypertension. Cochrane Database Syst Rev. (3), CD001841. doi: 10.1002/14651858.CD001841.pub2

Wiysonge, C. S., Bradley, H. A., Volmink, J., Mayosi, B. M., Mbewu, A., Opie, L. H. (2012). Beta-blockers for hypertension. Cochrane Database Syst Rev. 11, CD002003. doi: 10.1002/14651858.CD002003.pub4

Neimark, M. I., Merkulov, I. V. (2005). Anestezija I intensivnay terapija v hirurgii aorti I ee vetvei [Anesthesia and intensive care in surgery of the aorta and its branches]. Petrozavodsk: IntelTec, 272.

Organov, R. G., Mamedov, M. N. (2009). Nacionalnie klinicheskie rekomendacii Vserossiiskogo nauchnogo obshestva kardiologov [National clinical guidelines Russian Scientific Society of Cardiology]. Moscow: Medi Ecspo, 392.

Eboh, C., Chowdhury, T. A. (2015). Management of diabetic renal disease. Annals of Translational Medicine, 3 (11), 154. doi: 10.3978/j.issn.2305-5839.2015.06.25

Argyropoulos, C., Wang, K., Bernardo, J., Ellis, D., Orchard, T., Galas, D., Johnson, J. (2015). Urinary MicroRNA Profiling Predicts the Development of Microalbuminuria in Patients with Type 1 Diabetes. JCM, 4 (7), 1498–1517. doi: 10.3390/jcm4071498

Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Kirkman, M. S. et. al. (2011). Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus. Clinical Chemistry, 57 (6), e1–e47. doi: 10.1373/clinchem.2010.161596

Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H. et. al. (2013). 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation, 129 (25), S1–S45. doi: 10.1161/01.cir.0000437738.63853.7a

Mancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm et. al. (2013). 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Journal of Hypertension, 31 (7), 1281–1357. doi: 10.1097/01.hjh.0000431740.32696.cc

Ramezani, A., Saberian, P., Soheilian, M., Parsa, S. A., Kamali, H. K., Entezari, M., Shahbazi, M. M., Yaseri, M. (2014). Fundus autofluorescence in chronic essential hypertension. J. Ophthalmic. Vis. Res. 9 (3), 334–338.

Thompson, A. M., Hu, T., Eshelbrenner, C. L., Reynolds, K., He, J., Bazzano, L. A. (2011). Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension: a metaanalysis. JAMA. 305 (9), 913–922. doi: 10.1001/jama.2011.250

Fleisher, L. A., Fleischmann, K. E., Auerbach, A. D., Barnason, S. A., Beckman, J. A., Bozkurt, B. et. al. (2015). 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary. Journal of Nuclear Cardiology, 22 (1), 162–215. doi: 10.1007/s12350-014-0025-z

Chua, D., Ignaszewski, A. (2011). Angiotensin-converting enzyme inhibitors: An ACE in the hole for everyone? British Columbia Medical Journal, 53 (5), 220–223.

Rosenman, D. J., McDonald, F. S., Ebbert, J. O., Erwin, P. J., LaBella, M., Montori, V. M. (2008). Clinical consequences of withholding vs. administering renin-angiotensin-aldosterone system antagonists in the pre-operative period. J. Hosp. Med. 3 (4), 319–325. doi: 10.1002/jhm.323

Leibowitz, A. B. (2010). Can meta-analysis of the current literature help determine if peri-operative beta-blockers improve outcome of high-risk patients undergoing noncardiac surgery? Journal of Cardiothoracic and Vascular Anesthesia, 24 (2), 217–218. doi: 10.1053/j.jvca.2010.01.014

Law, M. R., Morris, J. K., Wald, N. J. (2009). Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. British Medical Journal, 338 (may19 1), b1665–b1665. doi: 10.1136/bmj.b1665

National Clinical Guideline Centre (UK). (2011). Hypertension: The clinical management of primary hypertension in adults: Update of clinical Guidelines 18 and 34, 1–16. Available at: http://www.nice.org.uk/guidance/CG127

Falaschetti, E., Chaudhury, M., Mindell, J., Poulter, N. (2009). Continued improvement in hypertension management in England: results from the Health Survey for England 2006. Hypertension. 53 (3), 480–486. doi: doi: 10.1161/hypertensionaha.108.125617

Aouad, M. T., Al-Alami, A. A., Nasr, V. G., Souki, F. G., Zbeidy, R. A., Siddik-Sayyid, S. M. (2009). The Effect of Low-Dose Remifentanil on Responses to the Endotracheal Tube During Emergence from General Anesthesia. Anesthesia & Analgesia, 108 (4), 1157–1160. doi: 10.1213/ane.0b013e31819b03d8

Meng, Y. F., Cui, G. X., Gao, W., Li, Z.-W. (2014). Local airway anesthesia attenuates hemodynamic responses to intubation and extubation in hypertensive surgical patients. Medical Science Monitor. 20, 1518–1524. doi: 10.12659/MSM.890703


GOST Style Citations


1. Pereira, M. Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries [Text] / M. Pereira, N. Lunet, A. Azevedo, N. Lunet // Journal of Hypertension. – 2009. – Vol. 27, Issue 5. – Р. 963–975. doi: 10.1097/hjh.0b013e3283282f65

2. Вершигора, А. В. Уніфікований клінічний протокол первинної, екстреної та вторинної (спеціалізованої) медичної допомоги (2012). Артеріальна гіпертензія [Текст] / А. В. Вершигора, В. О. Гранкіна, І. М. Гідзинська // Практикуючий лікар. – 2013. – № 4. – С. 59–63.

3. Lawes, C. M. Global burden of blood-pressure-related disease, 2001 [Text] / C. M. Lawes, V. S. Hoorn, A. Rodgers // Lancet. – 2008. – Vol. 371, Issue 9623. – P. 1513–1518. doi: 10.1016/S0140-6736(08)60655-8

4. Сиренко, Ю. Н. Гипертоническая болезнь и артериальные гипертензии [Текст] / Ю. Н. Сиренко. – Д.: Издатель Заславский А. Ю., 2011. – 288 с.

5. Свіщенко, Є. П. Рекомендації Української асоціації кардіологів з профілактики та лікування артеріальної гіпертензії (Посібник до Національної програми профілактики і лікування артеріальної гіпертензії. Четверте видання). [Текст] / Є. П. Свіщенко, А. Е. Багрій, Л. М. Єна та ін. – К : ПП ВМБ, 2008. – 80 с.

6. Прощаев, К. И. Тактика и особенности ведения больных с артериальной гипертензией в пожилом и старческом возрасте при хирургических вмешательствах [Текст]: дис. ... д-ра мед. наук: 14.00.52 / К. И. Прощаев. – Санкт-Петербургский институт биорегуляции и геронтологии Северо-Западного отделения РАМН. – Санкт-Петербург, 2005. – 305 с.

7. Mangano, D. T. Perioperative medicine: NHLBI working group deliberations and recommendations [Text] / D. T. Mangano // Journal of Cardiothoracic and Vascular Anesthesia. – 2004. – Vol. 18, Issue 1. – Р. 1–6. doi: 10.1053/j.jvca.2003.10.002

8. Manjula, S. Analysis of anaesthetic intensive care unit admissions: The anaesthesiologists' perspective [Text] / S. Manjula, D. Lalita, R. Shilpa // The Internet Journal of Anesthesiology. – 2007. – Vol. 13, Issue 1. – Р. 5–11.

9. Muggli, F. How to deal with preoperative hypertension [Text] / F. Muggli, P. M. Suter // Praxis (Bern 1994). – 2013. – Vol. 102, Issue 21. – Р. 1293–1297. doi: 10.1024/1661-8157/a001438

10. Faergeman, O. Efficacy and tolerability of rosuvastatin and atorvastatin when force titrated in high risk patients: Results from the ECLIPSE Study [Text] / O. Faergeman, F. Sosef, E. Duffield // Atherosclerosis Supplements. – 2006. – Vol. 7. – Р. 8–12.

11. Wright, J. M. First-line drugs for hypertension [Text] / J. M. Wright, V. M. Musini // Cochrane Database Syst Rev. – 2009. – Vol. 3. – P. CD001841. doi: 10.1002/14651858.CD001841.pub2

12. Wiysonge, C. S. Beta-blockers for hypertension [Text] / C. S.Wiysonge, H. A. Bradley, J. Volmink, B. M. Mayosi, A. Mbewu, L. H. Opie // Cochrane Database Syst. Rev. – 2012. – Vol. 11. – CD002003. doi: 10.1002/14651858.CD002003.pub4

13. Неймарк, М. И. Анестезия и интенсивная терапия в хирургии аорты и ее ветвей [Текст] / М. И. Неймарк, И. В. Меркулов. – Петрозаводск: ИнтелТек, 2005. – 272 с.

14. Национальные клинические рекомендации. Всероссийского научного общества кардиологов [Текст] / под. ред. Р. Г. Оганов, М. Н. Мамедов. – М.: МЕДИ Экспо, 2009. – 392 с.

15. Eboh, C. Management of diabetic renal disease [Text] / C. Eboh, T. A. Chowdhury // Annals of Translational Medicine. – 2015. – Vol. 3, Issue 11. – Р. 154. doi: 10.3978/j.issn.2305-5839.2015.06.25

16. Argyropoulos, C. Urinary microRNA profiling predicts the development of microalbuminuria in patients with Type 1 Diabetes [Text] / C. Argyropoulos, K. Wang, J. Bernardo, D. Ellis, T. Orchard, D. Galas, J. Johnson // Journal of Clinical Medicine. – 2015. – Vol. 4, Issue 7. – Р. 1498–1517. doi: 10.3390/jcm4071498

17. Sacks, D. B. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus [Text] / D. B. Sacks, M. Arnold, G. L. Bakris, D. E. Bruns, A. R. Horvath, M. S. Kirkman et. al. // Clinical Chemistry. – 2011. – Vol. 57, Issue 6. – Р. e1–e47. doi: 10.1373/clinchem.2010.161596

18. Stone, N. J. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [Text] / N. J. Stone, J. G. Robinson, A. H. Lichtenstein, C. N. Bairey Merz, C. B. Blum, R. H. Eckel et. al. // Circulation. – 2013. – Vol. 129, Issue 25_suppl_2. – Р. S1–S45. doi: 10.1161/01.cir.0000437738.63853.7a

19. Mancia, G. 2013 ESH/ESC Guidelines for themanagement of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) [Text] / G. Mancia, R. Fagard, K. Narkiewicz, J. Redón, A. Zanchetti, M. Böhm et. al. // Journal of Hypertension. – 2013. –Vol. 31, Issue 7. – Р. 1281–1357. doi: 10.1097/01.hjh.0000431740.32696.cc

20. Ramezani, A. Fundus autofluorescence in chronic essential hypertension [Text] / A. Ramezani, P. Saberian, M. Soheilian et al. // J. Ophthalmic. Vis. Res. – 2014. – Vol. 9, Issue 3. – Р. 334–338.

21. Thompson, A. M. Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension: a metaanalysis [Text] / A. M. Thompson, T. Hu, C. L. Eshelbrenner et al. // Journal of the American Medical Association. – 2011. – Vol. 305, Issue 9. – Р. 913–922. doi: 10.1001/jama.2011.250

22. Fleisher, L. A. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary [Text] / L. A. Fleisher, K. E. Fleischmann, A. D. Auerbach et al. // Journal of Nuclear Cardiology. – 2015. – Vol. 22, Issue 1. – Р. 162–215. doi: 10.1007/s12350-014-0025-z

23. Chua, D. Angiotensin-converting enzyme inhibitors: An ACE in the hole for everyone? [Text] / D. Chua, A. Ignaszewski // British Columbia Medical Journal. – 2011.– Vol. 53, Issue 5. – Р. 220–223.

24. Rosenman, D. J. Clinical consequences of withholding vs. administering renin-angiotensin-aldosterone system antagonists in the pre-operative period [Text] / D. J. Rosenman, F. S. McDonald, J. O. Ebbert et al. // Journal of Hospital Medicine. – 2008. – Vol. 3, Issue 4. – Р. 319–325. doi: 10.1002/jhm.323

25. Leibowitz, A. B. Can meta-analysis of the current literature help determine if peri-operative beta-blockers improve outcome of high-risk patients undergoing noncardiac surgery? [Text] / A. B. Leibowitz // Journal of Cardiothoracic and Vascular Anesthesia. – 2010. – Vol. 24, Issue 2. – Р. 217–218. doi: 10.1053/j.jvca.2010.01.014

26. Law, M. R. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies [Text] / M. R. Law, J. K. Morris, N. J. Wald // British Medical Journal. – 2009. – Vol. 338, Issue may19 1. – P. b1665– b1665. doi: 10.1136/bmj.b1665

27. Hypertension: The clinical management of primary hypertension in adults: Update of clinical Guidelines 18 and 34 [Electronic recourse]. – National Clinical Guideline Centre (UK). – 2011. – Р. 1–16. – Available at: http://www.nice.org.uk/guidance/CG127

28. Falaschetti, E. Continued improvement in hypertension management in England: results from the Health Survey for England 2006 [Text] / E. Falaschetti, M. Chaudhury, J. Mindell, N. Poulter // Hypertension. – 2009. – Vol. 53, Issue 3. – Р. 480–486. doi: 10.1161/hypertensionaha.108.125617

29. Aouad, M. T. The effect of low-dose remifentanil on responses to the endotracheal tube during emergence from general anesthesia [Text] / M. T. Aouad, A. A. Al-Alami, V. G. Nasr et al. // Anesthesia & Analgesia. – 2009. – Vol. 108, Issue 4. – Р. 1157–1160. doi: 10.1213/ane.0b013e31819b03d8

30. Meng, Y. F. Local airway anesthesia attenuates hemodynamic responses to intubation and extubation in hypertensive surgical patients [Text] / Y. F. Meng, G. X. Cui, W. Gao, Z.-W. Li // Medical Science Monitor. – 2014. – Vol. 20. – Р. 1518–1524. doi: 10.12659/MSM.890703







Copyright (c) 2015

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN 2313-8416 (Online), ISSN 2313-6286 (Print)